background
coronaviru
diseas
pose
larg
casualti
featur
patient
without
pneumonia
transmiss
asymptomat
carrier
factor
predict
diseas
progress
remain
unknown
method
collect
inform
clinic
characterist
exposur
histori
laboratori
examin
laboratoryconfirm
patient
admit
pla
gener
hospit
cox
regress
analysi
appli
identifi
prognost
factor
last
followup
februari
result
character
consecut
patient
mean
incub
confid
interv
ci
day
mean
durat
first
posit
test
convers
ci
day
cours
approxim
week
asymptomat
carrier
might
transmit
compar
patient
without
pneumonia
pneumonia
year
older
higher
rate
hypertens
higher
frequenc
fever
cough
higher
level
vs
b
lymphocyt
proport
low
account
cell
vs
multivari
cox
regress
analysi
indic
circul
lactat
independ
predict
progress
hazard
ratio
ci
respect
diseas
cours
lymphocyt
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
kind
coronavirus
cov
name
hcov
known
infect
human
caus
mild
upper
respiratori
infect
adult
occasion
sever
pneumonia
elder
infant
immunodefici
person
epidemiolog
data
indic
clear
evid
persontoperson
transmiss
transmiss
led
nosocomi
infect
case
number
increas
quickli
wuhan
pose
larg
casualti
februari
total
confirm
case
identifi
wuhan
estim
case
fatal
death
rapidli
spread
part
hubei
provinc
part
china
countri
result
case
death
estim
fatal
case
death
case
death
respect
februari
transmiss
higher
fatal
lower
compar
sarscov
although
two
cov
share
receptorhuman
angiotensin
convert
enzym
ii
etiolog
epidemiolog
clinic
characterist
epidem
wuhan
investig
sinc
diseas
outbreak
occurr
case
outsid
wuhan
report
differ
fatal
rate
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
indic
differ
epidem
pattern
among
outbreak
zone
outsid
area
rapidli
export
grow
number
countri
epidemiolog
clinic
featur
outsid
outbreak
zone
import
develop
prophylact
option
current
case
report
patient
pneumonia
rather
without
pneumonia
furthermor
diseas
cours
durat
viral
exist
transmiss
asymptomat
carrier
remain
unknown
report
seri
case
admit
infecti
diseas
hospit
respons
quarantin
treatment
assign
govern
beij
china
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
patient
pneumonia
met
one
follow
criteria
respiratori
rate
timesmin
rest
oxygen
satur
arteri
partial
pressur
oxygen
fraction
inspir
oxygen
fio
extrem
sever
type
met
one
follow
criteria
respiratori
failur
need
mechan
ventil
shock
combin
organ
failur
need
treat
intens
care
unit
patient
discharg
hospit
met
criteria
temperatur
normal
least
day
appar
improv
respiratori
symptom
absorpt
lung
inflamm
neg
genom
rna
test
twice
day
interv
final
date
followup
februari
categor
variabl
compar
use
test
fisher
exact
test
continu
variabl
describ
use
mean
median
interquartil
rang
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
iqr
valu
compar
use
independ
group
test
mannwhitney
u
test
cox
proport
hazard
model
appli
calcul
hazard
ratio
hr
confid
interv
ci
stepwis
backward
multivari
cox
regress
analysi
perform
determin
factor
independ
predict
progress
differ
daili
median
laboratori
paramet
patient
without
pneumonia
consecut
day
evalu
use
gener
estim
equat
gee
statist
analys
twosid
perform
use
spss
statist
packag
social
scienc
version
softwar
dynam
diagram
trend
laboratori
paramet
fit
local
polynomi
regress
loess
gener
r
softwar
version
p
valu
consid
signific
total
consecut
patient
laboratoryconfirm
enrol
studi
ever
travel
wuhan
came
wuhan
within
day
onset
direct
exposur
indirect
exposur
histori
within
day
ill
onset
case
ever
host
sick
rel
wuhan
ate
latediagnos
friend
wuhan
share
railway
carriag
patient
attend
meet
latediagnos
colleagu
confirm
case
increas
sinc
januari
reach
peak
januari
declin
gradual
ten
day
wuhan
quarantin
januari
curv
touch
bottom
figur
incub
period
calcul
use
data
case
clear
cut
time
point
exposur
ill
onset
mean
incub
period
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ci
day
case
mean
incub
ci
day
patient
without
pneumonia
ci
day
patient
pneumonia
patient
regular
examin
data
patient
one
coinfect
human
immunodefici
viru
hiv
hepat
b
viru
hbv
three
case
whose
sampl
intermitt
posit
exclud
mean
ci
durat
first
test
rtpcr
convers
remain
case
day
durat
day
patient
without
pneumonia
day
pneumonia
remain
case
without
approv
exposur
histori
unusu
exposur
patient
longterm
bedridden
infect
contact
healthi
famili
member
within
week
ill
onset
member
direct
indirect
exposur
histori
shortli
carri
emerg
depart
nearbi
hospit
replac
gastric
tube
highli
suspect
infect
patient
b
famili
member
exposur
histori
within
past
month
sister
sister
husband
wuhan
visit
famili
live
build
remot
suburb
beij
six
day
later
becam
ill
final
diagnos
entir
cours
sister
famili
member
ill
even
discomfort
indic
asymptomat
carrier
transmit
clinic
laboratori
paramet
patient
without
pneumonia
admiss
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
number
mild
common
sever
extrem
sever
patient
identifi
admiss
respect
common
sever
extrem
sever
type
combin
patient
pneumonia
compar
patient
without
pneumonia
pneumonia
year
older
higher
rate
hypertens
fever
cough
tabl
compar
patient
without
pneumonia
pneumonia
higher
level
b
lymphocyt
proport
erythrocyt
sediment
rate
low
count
cell
tabl
patient
receiv
antivir
treatment
mostli
lopinavirritonavir
arbidol
mean
durat
onset
admiss
tabl
evalu
dynam
clinic
laboratori
paramet
hospit
stay
patient
pneumonia
without
pneumonia
recategor
patient
progress
diseas
paramet
evalu
show
differ
trend
patient
without
pneumonia
p
gee
daili
median
neutrophil
proport
neutrophillymphocyt
ratio
nlr
higher
pneumonia
patient
pneumoniafre
patient
quit
contrast
lymphocyt
proport
lymphocyt
count
lymphocyt
count
lymphocyt
count
th
day
ill
onset
dynam
curv
neutrophil
proport
nlr
lymphocyt
proport
lymphocyt
count
tend
meet
p
except
lymphocyt
lymphocyt
count
p
figur
epidemiolog
clinic
featur
beij
might
repres
featur
outsid
outbreak
zone
patient
clear
exposur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
histori
indic
transmit
predominantli
via
respiratori
droplet
share
receptor
sarscov
reveal
mean
incub
infect
day
previou
studi
carri
wuhan
indic
mean
incub
period
day
earli
patient
identifi
outbreak
zone
mostli
sever
pneumonia
might
expos
higher
viral
concentr
close
space
like
affect
hospit
furthermor
hard
identifi
exact
time
exposur
outbreak
zone
thu
incub
studi
import
quarantin
close
contactor
outsid
outbreak
zone
durat
cours
cours
report
previous
determin
mean
durat
onset
discharg
day
accord
discharg
criteria
cours
approxim
week
quit
consist
sar
mean
durat
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
first
posit
test
rtpcr
convers
day
might
present
patient
around
day
ad
mean
incub
day
durat
seem
shorter
sar
knowledg
first
studi
character
differ
clinic
featur
laboratori
find
patient
without
pneumonia
unlik
without
pneumonia
onethird
patient
pneumonia
low
account
cell
addit
serum
level
higher
patient
pneumonia
without
pneumonia
tabl
data
suggest
cell
exhaust
inflamm
might
play
import
role
develop
critic
identifi
patient
like
poor
outcom
prevent
treatment
effort
focus
report
serum
lactat
admiss
independ
predict
poor
outcom
patient
adjust
signific
factor
univari
cox
analysi
tabl
capabl
inhibit
cellmedi
immun
high
level
acut
stage
associ
lung
lesion
sar
patient
lactat
natur
byproduct
aerob
glycolysi
efferocytosi
promot
glucos
uptak
lactat
releas
lactat
promot
switch
cell
subset
impair
cytolyt
capac
cell
thu
might
bridg
infect
alveolar
cell
injuri
via
induc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
tissuedamag
inflamm
inflamm
increas
efferocytosismedi
aerob
glycolysi
facilit
releas
lactat
increas
lactat
turn
impair
cellmedi
antivir
immun
first
time
dynam
chang
laboratori
paramet
patient
without
pneumonia
evalu
hospit
stay
neutrophil
proport
nlr
higher
pneumonia
patient
pneumoniafre
patient
indic
system
inflamm
appar
lymphocyt
proport
lymphocyt
count
lower
pneumonia
patient
pneumoniafre
two
curv
met
day
indic
b
cell
might
recov
rapidli
surprisingli
lower
level
cell
pneumonia
patient
increas
day
figur
indic
recoveri
cellmedi
immun
need
longer
time
thu
discharg
patient
might
suscept
infect
diseas
recoveri
cell
count
monitor
studi
sever
limit
first
effect
antivir
treatment
evalu
due
lack
control
second
famili
member
patient
b
sister
examin
left
perform
studi
third
half
patient
still
hospit
diseas
cours
sever
patient
might
prolong
therapeut
regimen
includ
corticosteroid
final
character
epidemiolog
featur
includ
incub
period
time
rtpcr
convers
cours
transmiss
asymptomat
carrier
old
age
hypertens
cell
exhaust
significantli
associ
develop
pneumonia
circul
lactat
independ
predict
progress
cell
exhaust
might
import
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
progress
studi
elucid
mechan
progress
also
provid
epidemiolog
evid
prevent
epidem
outsid
outbreak
zone
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
wuhandirect
patient
travel
wuhan
came
wuhan
within
day
ill
onset
wuhanindirect
patient
ever
expos
latediagnos
patient
wuhan
within
day
ill
onset
explicit
contact
histori
patient
situat
daili
median
laboratori
paramet
within
first
day
appli
construct
dynam
curv
p
valu
indic
differ
laboratori
paramet
th
th
day
sinc
ill
onset
mannwhitney
u
test
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
